Wiz Research just found a major AI security exposure—DeepSeek had a publicly accessible database leaking sensitive ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), a biopharmaceutical ...

Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...

Most people don’t have any problems from viscosupplementation. But a small number of people do have problems. The most common problem you might have is a flare-up of your arthritis just after your ...

On Thursday, RBI injected more than ₹1.45 lakh crore via two overnight variable rate repo (VRR) auctions and a buyback operation of ₹9,666 crore. The RBI will conduct a similar VRR auction on Friday ...

Alongside that, there has been a massive injection of technology into the ... and likely different tiers of service at different price points. “The body scan today is kind of the iPod moment ...

AMD hasn’t yet confirmed the RX 9070 specs, but a recent RX 9070 specs leak suggests the new GPU will house 3,584 stream processors, running at up to 2,520MHz, with a base clock speed of 2,070MHz.

OpenAI-owned ChatGPT might have a vulnerability that could allow threat actors to launch distributed denial of service (DDoS ... The same API is open to prompt injection attacks According to ...

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information ...

Apellis Pharmaceuticals' drug pegcetacoplan, which was approved by the FDA for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), has raised safety concerns due to ...